{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T07:23:17Z","timestamp":1789716197238,"version":"4.0.1"},"reference-count":99,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T00:00:00Z","timestamp":1729036800000},"content-version":"vor","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico (English Edition)"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.rgmxen.2024.10.008","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T22:47:16Z","timestamp":1729810036000},"page":"521-532","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Gastrointestinal adverse effects of old and new antidiabetics: How do we deal with them in real life?"],"prefix":"10.1016","volume":"89","author":[{"given":"J.R.","family":"Barrientos-\u00c1valos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.C.","family":"Morel-Cerda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.A.","family":"F\u00e9lix-T\u00e9llez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.E.","family":"Vidrio-Huerta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.R.","family":"Aceves-Ayala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1.R.","family":"Flores-Rend\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Velarde-Ruiz Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rgmxen.2024.10.008_bib0005","series-title":"IDF Diabetes Atlas","author":"Magliano","year":"2021"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.108927","article-title":"Regional and state-level patterns of type 2 diabetes prevalence in Mexico over the last three decades","volume":"177","author":"Seiglie","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0015","doi-asserted-by":"crossref","first-page":"S163","DOI":"10.21149\/14832","article-title":"Prevalence of prediabetes and diabetes in Mexico: Ensanut 2022","volume":"65","author":"Basto-Abreu","year":"2023","journal-title":"Salud Publica Mex"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0020","author":"S\u00e1nchez-Morales"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0025","article-title":"Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials","volume":"381","author":"Shi","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0030","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1055\/s-0034-1375676","article-title":"Effects of acarbose on polycystic ovary syndrome: a meta-analysis","volume":"122","author":"Zhang","year":"2014","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0035","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s12325-020-01602-9","article-title":"The Effects of acarbose on non-diabetic overweight and obese patients: a meta-analysis","volume":"38","author":"Yu","year":"2021","journal-title":"Adv Ther"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0040","first-page":"2802","article-title":"Efficacy and safety of combination therapy with vildagliptin and metformin vs. metformin monotherapy for Type 2 Diabetes Mellitus therapy: a meta-analysis","volume":"26","author":"Ding","year":"2022","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.108824","article-title":"Metformin extended-release versus metformin immediate-release for adults with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials","volume":"178","author":"Abrilla","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0050","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.712200","article-title":"Comparison of clinical efficacy and safety of metformin sustained-release tablet (ii) (dulening) and metformin tablet (glucophage) in treatment of type 2 diabetes mellitus","volume":"12","author":"Guo","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0055","doi-asserted-by":"crossref","first-page":"G424","DOI":"10.1152\/ajpgi.2002.282.3.G424","article-title":"Effect of GLP-1 on gastric volume, emptying, maximum volume ingested, and postprandial symptoms in humans","volume":"282","author":"Delgado-Aros","year":"2002","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0060","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2147\/DMSO.S348025","article-title":"Difference in gastrointestinal risk associated with use of GLP-1 receptor agonists: a real-world pharmacovigilance study","volume":"15","author":"Zhou","year":"2022","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0065","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1365-2982.2007.01079.x","article-title":"GLP-1 suppresses gastrointestinal motility and inhibits the migrating motor complex in healthy subjects and patients with irritable bowel syndrome","volume":"20","author":"Hellstr\u00f6m","year":"2008","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0070","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s40262-018-0728-4","article-title":"Safety and pharmacokinetics of single and multiple ascending doses of the novel oral human GLP-1 analogue, oral semaglutide, in healthy subjects and subjects with type 2 diabetes","volume":"58","author":"Granhall","year":"2019","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0075","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2337\/dc17-1536","article-title":"Gastrointestinal symptoms in diabetes: prevalence, assessment, pathogenesis, and management","volume":"41","author":"Du","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0080","doi-asserted-by":"crossref","first-page":"S231","DOI":"10.2337\/dc24-S012","article-title":"12. Retinopathy, neuropathy, and foot care: standards of care in diabetes\u20142024","volume":"47","author":"ElSayed","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0085","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2337\/dc07-1154","article-title":"Prevalence of depression among U.S. adults with diabetes: findings from the 2006 behavioral risk factor surveillance system","volume":"31","author":"Li","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0090","doi-asserted-by":"crossref","DOI":"10.1177\/1756284819852047","article-title":"Pathophysiology and management of diabetic gastroenteropathy","volume":"12","author":"Meldgaard","year":"2019","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0095","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3827301","article-title":"Diabetic enteropathy: from molecule to mechanism-based treatment","volume":"2018","author":"Meldgaard","year":"2018","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0100","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1007\/s11845-022-03191-8","article-title":"Diabetic gastroparesis: clinical features, diagnosis and management","volume":"192","author":"Ahmed","year":"2023","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0105","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.14309\/ajg.0000000000001874","article-title":"ACG clinical guideline: gastroparesis","volume":"117","author":"Camilleri","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0110","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF00186645","article-title":"Relationships between oesophageal transit and solid and liquid gastric emptying in diabetes mellitus","volume":"18","author":"Horowitz","year":"1991","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0115","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.2337\/diacare.24.7.1264","article-title":"Predictors of delayed gastric emptying in diabetes","volume":"24","author":"Jones","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0120","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nrendo.2014.202","article-title":"Gastric emptying and glycaemia in health and diabetes mellitus","volume":"11","author":"Phillips","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0125","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1056\/NEJMra2020927","article-title":"Gastric emptying abnormalities in diabetes mellitus","volume":"384","author":"Goyal","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0130","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1111\/j.1572-0241.2000.02006.x","article-title":"Proximal gastric compliance and perception of distension in type 1 diabetes mellitus: effects of hyperglycemia","volume":"95","author":"Rayner","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0135","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1053\/jcrc.2002.33030","article-title":"Abdominal pain in patients with hyperglycemic crises","volume":"17","author":"Umpierrez","year":"2002","journal-title":"J Crit Care"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0140","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1210\/jc.2005-0513","article-title":"Insulin-induced hypoglycemia accelerates gastric emptying of solids and liquids in long-standing type 1 diabetes","volume":"90","author":"Russo","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0145","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/595649","article-title":"Exocrine pancreatic insufficiency in diabetic patients: prevalence, mechanisms, and treatment","volume":"2015","author":"Piciucchi","year":"2015","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0150","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/apt.14451","article-title":"Systematic review: human gut dysbiosis induced by non-antibiotic prescription medications","volume":"47","author":"Le Bastard","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0155","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3389\/fendo.2020.00444","article-title":"Neuroendocrine and metabolic effects of low-calorie and non-calorie sweeteners","volume":"11","author":"Moriconi","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0160","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.988144","article-title":"Non-nutritive sweeteners and their impacts on the gut microbiome and host physiology","volume":"9","author":"Richardson","year":"2022","journal-title":"Front Nutr"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0165","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1741-7015-3-8","article-title":"Psychological illness is commonly associated with functional gastrointestinal disorders and is important to consider during patient consultation: a population-based study","volume":"3","author":"\u00c5lander","year":"2005","journal-title":"BMC Med"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0170","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.diabres.2012.01.021","article-title":"Gastrointestinal symptoms in diabetes mellitus, and their relation to anxiety and depression","volume":"96","author":"de Kort","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0175","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/j.1572-0241.2001.03605.x","article-title":"Psychological distress is linked to gastrointestinal symptoms in diabetes mellitus","volume":"96","author":"Talley","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0180","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1256705","article-title":"The anti-diabetic effects of metformin are mediated by regulating long non-coding RNA","volume":"14","author":"Chang","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0185","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41574-023-00833-4","article-title":"Metformin: update on mechanisms of action and repurposing potential","volume":"19","author":"Foretz","year":"2023","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102171","article-title":"Metformin reduces macrophage HIF1\u03b1-dependent proinflammatory signaling to restore brown adipocyte function in vitro","volume":"48","author":"Pescador","year":"2021","journal-title":"Redox Biol"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0195","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1080\/14656566.2019.1672660","article-title":"Considerations when using alpha-glucosidase inhibitors in the treatment of type 2 diabetes","volume":"20","author":"Hedrington","year":"2019","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0200","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/S0140-6736(06)69705-5","article-title":"The incretin system glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes","volume":"368","author":"Drucker","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0205","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/dom.13129","article-title":"Incretin hormones: their role in health and disease","volume":"20","author":"Nauck","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0210","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/j.clinthera.2017.07.036","article-title":"Gastrointestinal adverse events of dipeptidyl peptidase 4 inhibitors in type 2 diabetes: a systematic review and network meta-analysis","volume":"39","author":"Wu","year":"2017","journal-title":"Clin Ther"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0215","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1210\/clinem\/dgac210","article-title":"Cardiovascular benefits of empagliflozin are associated with gut microbiota and plasma metabolites in type 2 diabetes","volume":"107","author":"Deng","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0220","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.diabet.2019.11.005","article-title":"Effects of 12-week treatment with dapagliflozin and gliclazide on faecal microbiome: Results of a double-blind randomized trial in patients with type 2 diabetes","volume":"46","author":"Van Bommel","year":"2020","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0225","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1080\/00325481.2015.1090295","article-title":"User\u2019s guide to mechanism of action and clinical use of GLP-1 receptor agonists","volume":"127","author":"Shaefer","year":"2015","journal-title":"Postgrad Med"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0230","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/00325481.2021.2002616","article-title":"Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations for clinical practice","volume":"134","author":"Wharton","year":"2022","journal-title":"Postgrad Med"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0235","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/dom.14551","article-title":"Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss","volume":"24","author":"Wharton","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0240","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1043789","article-title":"Association between different GLP-1 receptor agonists and gastrointestinal adverse reactions: a real-world disproportionality study based on FDA adverse event reporting system database","volume":"13","author":"Liu","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0245","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1053\/j.gastro.2016.03.035","article-title":"Rome IV - Functional GI disorders: disorders of gut-brain interaction","volume":"150","author":"Drossman","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0250","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/ueg2.12061","article-title":"United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia","volume":"9","author":"Wauters","year":"2021","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0255","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ueg2.12060","article-title":"United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis","volume":"9","author":"Schol","year":"2021","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0260","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/dmrr.499","article-title":"Effectiveness of progressive dose-escalation of exenatide (exendin-4) in reducing dose-limiting side effects in subjects with type 2 diabetes","volume":"20","author":"Fineman","year":"2004","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0265","doi-asserted-by":"crossref","first-page":"16684","DOI":"10.1038\/s41598-021-95117-0","article-title":"Metformin treatment for 8 days impacts multiple intestinal parameters in high-fat high-sucrose fed mice","volume":"11","author":"Bravard","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0270","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.626359","article-title":"Metformin strongly affects gut microbiome composition in high-fat diet-induced type 2 diabetes mouse model of both sexes","volume":"12","author":"Silami\u0137ele","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0275","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/dc20-2257","article-title":"Metformin affects gut microbiome composition and function and circulating short-chain fatty acids: a randomized trial","volume":"44","author":"Mueller","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0280","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1007\/s00125-019-4848-7","article-title":"Metformin-induced changes of the gut microbiota in healthy young men: results of a non-blinded, one-armed intervention study","volume":"62","author":"Bryrup","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0285","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1125187","article-title":"The effects of prebiotics on gastrointestinal side effects of metformin in youth: a pilot randomized control trial in youth-onset type 2 diabetes","volume":"14","author":"Dixon","year":"2023","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0290","doi-asserted-by":"crossref","first-page":"925","DOI":"10.5152\/tjg.2022.211063","article-title":"Metformin with versus without concomitant probiotic therapy in newly diagnosed patients with type 2 diabetes or prediabetes: a comparative analysis in relation to glycemic control, gastrointestinal side effects, and treatment compliance","volume":"33","author":"Sahin","year":"2022","journal-title":"Turk J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2023.110806","article-title":"Effects of combined treatment of probiotics and metformin in management of type 2 diabetes: a systematic review and meta-analysis","volume":"202","author":"Memon","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0300","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.3390\/nu13062107","article-title":"Habitual dietary intake affects the altered pattern of gut microbiome by acarbose in patients with type 2 diabetes","volume":"13","author":"Takewaki","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0305","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S2213-8587(17)30309-1","article-title":"Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial","volume":"5","author":"Holman","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0310","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.573891","article-title":"Effects of non-insulin anti-hyperglycemic agents on gut microbiota: a systematic review on human and animal studies","volume":"11","author":"Cao","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0315","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s13300-017-0226-y","article-title":"Effects of acarbose on the gut microbiota of prediabetic patients: a randomized, double-blind, controlled crossover trial","volume":"8","author":"Zhang","year":"2017","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0320","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/1753-0407.12232","article-title":"Acarbose treatment affects the serum levels of inflammatory cytokines and the gut content of bifidobacteria in Chinese patients with type 2 diabetes mellitus","volume":"7","author":"Su","year":"2015","journal-title":"J Diabetes"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0325","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.3390\/nu14235139","article-title":"The effect of prebiotics and oral anti-diabetic agents on gut microbiome in patients with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials","volume":"14","author":"Ojo","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0330","doi-asserted-by":"crossref","first-page":"940","DOI":"10.3390\/nu9090940","article-title":"Low-FODMAP diet improves irritable bowel syndrome symptoms: a meta-analysis","volume":"9","author":"Altobelli","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0335","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/gutjnl-2016-312456","article-title":"Functional variants in the sucrase-isomaltase gene associate with increased risk of irritable bowel syndrome","volume":"67","author":"Henstr\u00f6m","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0340","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1079\/BJN20031063","article-title":"Starch digestion, large-bowel fermentation and intestinal mucosal cell proliferation in rats treated with the \u03b1-glucosidase inhibitor acarbose","volume":"91","author":"Dehghan-Kooshkghazi","year":"2004","journal-title":"Br J Nutr"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0345","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1136\/gutjnl-2021-325214","article-title":"Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis","volume":"71","author":"Black","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0350","doi-asserted-by":"crossref","first-page":"13167","DOI":"10.1111\/nmo.13167","article-title":"Effect of intragastric FODMAP infusion on upper gastrointestinal motility, gastrointestinal, and psychological symptoms in irritable bowel syndrome vs healthy controls","volume":"30","author":"Masuy","year":"2018","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0355","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3389\/fphar.2019.00777","article-title":"Head-to-head comparison of the hypoglycemic efficacy and safety between dipeptidyl peptidase-4 inhibitors and \u03b1-glucosidase inhibitors in patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials","volume":"10","author":"Li","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0360","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/dom.12174","article-title":"Efficacy and safety of dipeptidyl peptidase-4 inhibitors and metformin as initial combination therapy and as monotherapy in patients with type 2 diabetes mellitus: a meta-analysis","volume":"16","author":"Wu","year":"2014","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0365","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1530\/EJE-14-0314","article-title":"The impact of dipeptidyl peptidase 4 inhibition on incretin effect, glucose tolerance, and gastrointestinal-mediated glucose disposal in healthy subjects","volume":"171","author":"Rhee","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0370","doi-asserted-by":"crossref","first-page":"7184","DOI":"10.3390\/ijms24087184","article-title":"The effects of cardioprotective antidiabetic therapy on microbiota in patients with type 2 diabetes mellitus\u2014a systematic review","volume":"24","author":"Bica","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12876-021-01613-y","article-title":"Short chain fatty acids and colon motility in a mouse model of irritable bowel syndrome","volume":"21","author":"Shaidullov","year":"2021","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0380","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1111\/nmo.12425","article-title":"The short chain fatty acids, butyrate and propionate, have differential effects on the motility of the guinea pig colon","volume":"26","author":"Hurst","year":"2014","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201410","article-title":"A low FODMAP diet is associated with changes in the microbiota and reduction in breath hydrogen but not colonic volume in healthy subjects","volume":"13","author":"Sloan","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0390","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/gutjnl-2018-316405","article-title":"Association between delayed gastric emptying and upper gastrointestinal symptoms: a systematic review and meta-analysis","volume":"68","author":"Vijayvargiya","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0395","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1053\/j.gastro.2021.10.028","article-title":"Gastroparesis","volume":"162","author":"Camilleri","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0400","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/BF00400569","article-title":"Hyperglycaemia slows gastric emptying in Type 1 (insulin-dependent) diabetes mellitus","volume":"33","author":"Fraser","year":"1990","journal-title":"Diabetologia"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0405","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0016-5085(97)70080-5","article-title":"Physiological hyperglycemia slows gastric emptying in normal subjects and patients with insulin-dependent diabetes mellitus","volume":"113","author":"Schvarcz","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0410","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1572-0241.2007.01636.x","article-title":"Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine","volume":"103","author":"Abell","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0415","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3390\/jcm12010145","article-title":"Clinical recommendations to manage gastrointestinal adverse events in patients treated with Glp-1 receptor agonists: a multidisciplinary expert consensus","volume":"12","author":"Gorgojo-Mart\u00ednez","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0420","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1093\/advances\/nmac037","article-title":"Dietary interventions for gastroparesis: a systematic review","volume":"13","author":"Eseonu","year":"2022","journal-title":"Adv Nutr"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0425","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/nmo.12519","article-title":"Effect of dietary fat and food consistency on gastroparesis symptoms in patients with gastroparesis","volume":"27","author":"Homko","year":"2015","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0430","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/ajg.2013.453","article-title":"A small particle size diet reduces upper gastrointestinal symptoms in patients with diabetic gastroparesis: a randomized controlled trial","volume":"109","author":"Olausson","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0435","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1463-1326.2012.01557.x","article-title":"Liraglutide: short-lived effect on gastric emptying--long lasting effects on body weight","volume":"14","author":"Jelsing","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0440","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(08)61206-4","article-title":"Articles Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study","volume":"372","author":"Drucker","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0445","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-8587(15)00436-2","article-title":"Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial","volume":"4","author":"Dejgaard","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0450","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/j.1464-5491.2010.03085.x","article-title":"Prophylactic use of anti-emetic medications reduced nausea and vomiting associated with exenatide treatment: a retrospective analysis of an open-label, parallel-group, single-dose study in healthy subjects","volume":"27","author":"Ellero","year":"2010","journal-title":"Diabet Med"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0455","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1053\/j.gastro.2019.01.249","article-title":"Effects of promotility agents on gastric emptying and symptoms: a systematic review and meta-analysis","volume":"156","author":"Vijayvargiya","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0460","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/ueg2.12362","article-title":"Do prokinetic agents provide symptom relief through acceleration of gastric emptying? An update and revision of the existing evidence","volume":"11","author":"Goelen","year":"2023","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0465","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1053\/j.gastro.2022.12.014","article-title":"Efficacy and safety of drugs for gastroparesis: systematic review and network meta-analysis","volume":"164","author":"Ingrosso","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0470","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1053\/j.gastro.2023.03.214","article-title":"American Gastroenterological Association-American College of Gastroenterology clinical practice guideline: pharmacological management of chronic idiopathic constipation","volume":"164","author":"Chang","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0475","first-page":"349","article-title":"Exendin-4, an analogue of glucagon-like peptide-1, attenuates hyperalgesia through serotonergic pathways in rats with neonatal colonic sensitivity","volume":"65","author":"Yang","year":"2014","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0480","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/MCG.0000000000001143","article-title":"Implementation of a defecation posture modification device: impact on bowel movement patterns in healthy subjects","volume":"53","author":"Modi","year":"2019","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0485","doi-asserted-by":"crossref","first-page":"14070","DOI":"10.1111\/nmo.14070","article-title":"Chronic constipation in adults: contemporary perspectives and clinical challenges. 2: conservative, behavioural, medical and surgical treatment","volume":"33","author":"Corsetti","year":"2021","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0490","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.14309\/ajg.0000000000000304","article-title":"Prucalopride in gastroparesis: a randomized placebo-controlled crossover study","volume":"114","author":"Carbone","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.10.008_bib0495","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1046\/j.1365-2036.2002.01272.x","article-title":"Prucalopride, a systemic enterokinetic, for the treatment of constipation","volume":"16","author":"Emmanuel","year":"2002","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2255534X24001002?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2255534X24001002?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T12:33:10Z","timestamp":1732019590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2255534X24001002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":99,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2255534X24001002"],"URL":"https:\/\/doi.org\/10.1016\/j.rgmxen.2024.10.008","relation":{},"ISSN":["2255-534X"],"issn-type":[{"value":"2255-534X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gastrointestinal adverse effects of old and new antidiabetics: How do we deal with them in real life?","name":"articletitle","label":"Article Title"},{"value":"Revista de Gastroenterolog\u00eda de M\u00e9xico (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rgmxen.2024.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.rgmx.2024.07.001","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Asociaci\u00f3n Mexicana de Gastroenterolog\u00eda. Published by Masson Doyma M\u00e9xico S.A.","name":"copyright","label":"Copyright"}]}}